| |
CNV = 2
|
CNV > 2
|
P value
|
|---|
|
Age at diagnosis (years)
|
60.4 ± 14.5
|
61.4 ± 13.6
|
0.74
|
|
Menopausal status
|
0.70
|
|
Premenopausal
|
20.9%
|
10%
|
|
Perimenopausal
|
3.7%
|
0.0%
|
|
Menopausal
|
75.4%
|
90%
|
|
Estrogen receptor
|
0.84
|
|
Positive
|
67.8%
|
80%
|
|
Negative
|
32.2%
|
20%
|
|
Progesterone receptor
|
0.35
|
|
Positive
|
53%
|
30%
|
|
Negative
|
47%
|
70%
|
|
HER-2 status
|
0.99
|
|
Positive
|
70.1%
|
70%
|
|
Negative
|
29.9%
|
30%
|
|
Palpable tumour
|
0.07
|
|
Yes
|
93.6%
|
70%
|
|
No
|
6.4%
|
30%
|
|
Lymph node status
|
0.04*
|
|
Negative
|
58.2%
|
80%
|
|
Positive
|
41.8%
|
20%
|
|
Tumour type
|
0.93
|
|
Invasive ductal carcinoma (IDC)
|
72.9%
|
80%
|
|
Ductal carcinoma in situ (DCIS)
|
5.7%
|
0.0%
|
|
Lobular
|
15.7%
|
20%
|
|
D & L
|
1%
|
0.0%
|
|
Other
|
2.9%
|
0.0%
|
|
Histological grade
|
0.36
|
|
I
|
11.1%
|
0%
|
|
II
|
51.9%
|
70%
|
|
III
|
37%
|
30%
|
|
Location
|
0.04*
|
|
Unilateral
|
95.5%
|
80%
|
|
Bilateral
|
2.5%
|
20%
|
|
Familial history
|
0.001*
|
|
Yes
|
45%
|
100%
|
|
No
|
55%
|
0%
|
|
Size (cm)
|
0.64
|
|
< 2
|
59%
|
60%
|
|
> 2
|
41%
|
40%
|
|
Vascular invasion
|
0.21
|
|
Yes
|
81%
|
0%
|
|
No
|
19%
|
100%
|
